378800 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Shaperon, Inc. engages in the drug development for Atopy dermatitis, septicemia and Alzheimer. The company was founded in October, 2008 and is headquartered in Seoul, South Korea.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
378800 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company